|
Name |
N-Deoxymilitarinone A
|
Molecular Formula | C26H37NO5 | |
IUPAC Name* |
5-(1,4-dihydroxycyclohexyl)-4-hydroxy-3-[(2E,4E,6E,8R,10R)-6,8,10-trimethyldodeca-2,4,6-trienoyl]-1H-pyridin-2-one
|
|
SMILES |
CC[C@@H](C)C[C@@H](C)/C=C(\C)/C=C/C=C/C(=O)C1=C(C(=CNC1=O)C2(CCC(CC2)O)O)O
|
|
InChI |
InChI=1S/C26H37NO5/c1-5-17(2)14-19(4)15-18(3)8-6-7-9-22(29)23-24(30)21(16-27-25(23)31)26(32)12-10-20(28)11-13-26/h6-9,15-17,19-20,28,32H,5,10-14H2,1-4H3,(H2,27,30,31)/b8-6+,9-7+,18-15+/t17-,19-,20?,26?/m1/s1
|
|
InChIKey |
CFXXFGCOVLKQAW-ZUOACUPQSA-N
|
|
Synonyms |
N-DEOXYMILITARINONE A; (+)-N-deoxymilitarinone A; CHEMBL481849
|
|
CAS | NA | |
PubChem CID | 54707854 | |
ChEMBL ID | CHEMBL481849 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 443.6 | ALogp: | 4.5 |
HBD: | 4 | HBA: | 5 |
Rotatable Bonds: | 9 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 107.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 32 | QED Weighted: | 0.244 |
Caco-2 Permeability: | -4.974 | MDCK Permeability: | 0.00001140 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.198 |
Human Intestinal Absorption (HIA): | 0.055 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.383 |
Blood-Brain-Barrier Penetration (BBB): | 0.06 | Plasma Protein Binding (PPB): | 93.89% |
Volume Distribution (VD): | 0.701 | Fu: | 8.38% |
CYP1A2-inhibitor: | 0.611 | CYP1A2-substrate: | 0.628 |
CYP2C19-inhibitor: | 0.771 | CYP2C19-substrate: | 0.187 |
CYP2C9-inhibitor: | 0.907 | CYP2C9-substrate: | 0.993 |
CYP2D6-inhibitor: | 0.945 | CYP2D6-substrate: | 0.892 |
CYP3A4-inhibitor: | 0.881 | CYP3A4-substrate: | 0.183 |
Clearance (CL): | 2.084 | Half-life (T1/2): | 0.187 |
hERG Blockers: | 0.052 | Human Hepatotoxicity (H-HT): | 0.424 |
Drug-inuced Liver Injury (DILI): | 0.485 | AMES Toxicity: | 0.103 |
Rat Oral Acute Toxicity: | 0.534 | Maximum Recommended Daily Dose: | 0.955 |
Skin Sensitization: | 0.664 | Carcinogencity: | 0.155 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.129 |
Respiratory Toxicity: | 0.917 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005829 | 0.371 | D00DKK | 0.227 | ||||
ENC002822 | 0.361 | D0G3PI | 0.227 | ||||
ENC002137 | 0.333 | D02DGU | 0.227 | ||||
ENC003253 | 0.324 | D0S7WX | 0.220 | ||||
ENC006056 | 0.321 | D01CKY | 0.219 | ||||
ENC003005 | 0.319 | D08SVH | 0.207 | ||||
ENC002361 | 0.314 | D0FG6M | 0.203 | ||||
ENC004780 | 0.310 | D04GJN | 0.202 | ||||
ENC002883 | 0.310 | D0N3NO | 0.201 | ||||
ENC002839 | 0.310 | D04ATM | 0.200 |